Stay updated on Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131.
    Difference
    0.0%
    Check dated 2026-03-26T02:53:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Melanoma and related topics (MedlinePlus Genetics) and updated site revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T20:37:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:00:19.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Removed the Melanoma condition tag and the MedlinePlus Genetics related topic link from the study page.
    Difference
    0.1%
    Check dated 2026-03-04T15:24:53.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added related topics: Melanoma and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-02-25T10:39:26.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The changes remove the related topics Melanoma and MedlinePlus Genetics from the page's topics section, which does not affect core trial data or the primary purpose of the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T06:55:38.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.